Carl Wayne Stevens Ii, MD | |
203 S 12th Ave, Laurel, MS 39440-4324 | |
(601) 649-9706 | |
(601) 649-9708 |
Full Name | Carl Wayne Stevens Ii |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 31 Years |
Location | 203 S 12th Ave, Laurel, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336246446 | NPI | - | NPPES |
00119265 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 15762 (Mississippi) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
South Central Reg Med Ctr | Laurel, MS | Hospital |
Anderson Regional Medical Ctr | Meridian, MS | Hospital |
Wayne General Hospital | Waynesboro, MS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ear,nose And Throat Surgical Clinic Of South Central Ms | 1456444546 | 5 |
News Archive
Elderly patients undergoing PCI often receive bare-metal stents (BMS) instead of drug-eluting stents (DES) to shorten the duration of dual antiplatelet therapy (DAPT) and reduce bleeding risk. However, results from the SENIOR trial found that compared with BMS, shorter DAPT combined with the Synergy bioabsorbable polymer DES leads to less adverse events without increasing bleeding risk.
Thanks to a new diagnostic imaging technique, physicians now have an objective test to evaluate patients for parkinsonian syndromes, such as Parkinson's disease. Northwestern Memorial Hospital is among the first institutions in the country to offer DaTscan-, the only FDA-approved imaging agent for assessment of movement disorders.
Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that it has received funding to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 (WISP1) for the potential treatment of IPF, which affects more than 100,000 Americans.
There is currently no evidence that the 2019 novel coronavirus disease (COVID-19) causes severe adverse outcomes in neonates or that it can pass to the child while in the womb, according to a small observational study of women from Wuhan, China, who were in the third trimester of pregnancy and had pneumonia caused by COVID-19.
› Verified 4 days ago
Entity Name | Ear,nose & Throat Surgical Clinic Of South Central Ms |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033312772 PECOS PAC ID: 1456444546 Enrollment ID: O20070905000746 |
News Archive
Elderly patients undergoing PCI often receive bare-metal stents (BMS) instead of drug-eluting stents (DES) to shorten the duration of dual antiplatelet therapy (DAPT) and reduce bleeding risk. However, results from the SENIOR trial found that compared with BMS, shorter DAPT combined with the Synergy bioabsorbable polymer DES leads to less adverse events without increasing bleeding risk.
Thanks to a new diagnostic imaging technique, physicians now have an objective test to evaluate patients for parkinsonian syndromes, such as Parkinson's disease. Northwestern Memorial Hospital is among the first institutions in the country to offer DaTscan-, the only FDA-approved imaging agent for assessment of movement disorders.
Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that it has received funding to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 (WISP1) for the potential treatment of IPF, which affects more than 100,000 Americans.
There is currently no evidence that the 2019 novel coronavirus disease (COVID-19) causes severe adverse outcomes in neonates or that it can pass to the child while in the womb, according to a small observational study of women from Wuhan, China, who were in the third trimester of pregnancy and had pneumonia caused by COVID-19.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Carl Wayne Stevens Ii, MD 203 S 12th Ave, Laurel, MS 39440-4324 Ph: (601) 649-9706 | Carl Wayne Stevens Ii, MD 203 S 12th Ave, Laurel, MS 39440-4324 Ph: (601) 649-9706 |
News Archive
Elderly patients undergoing PCI often receive bare-metal stents (BMS) instead of drug-eluting stents (DES) to shorten the duration of dual antiplatelet therapy (DAPT) and reduce bleeding risk. However, results from the SENIOR trial found that compared with BMS, shorter DAPT combined with the Synergy bioabsorbable polymer DES leads to less adverse events without increasing bleeding risk.
Thanks to a new diagnostic imaging technique, physicians now have an objective test to evaluate patients for parkinsonian syndromes, such as Parkinson's disease. Northwestern Memorial Hospital is among the first institutions in the country to offer DaTscan-, the only FDA-approved imaging agent for assessment of movement disorders.
Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that it has received funding to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 (WISP1) for the potential treatment of IPF, which affects more than 100,000 Americans.
There is currently no evidence that the 2019 novel coronavirus disease (COVID-19) causes severe adverse outcomes in neonates or that it can pass to the child while in the womb, according to a small observational study of women from Wuhan, China, who were in the third trimester of pregnancy and had pneumonia caused by COVID-19.
› Verified 4 days ago
Dr. Michael Pollard Brooks, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 128 S 11th Ave, Laurel, MS 39440 Phone: 601-649-8732 Fax: 601-649-5051 | |
Jamie Don Sisk, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 203 S 12th Ave, Laurel, MS 39440 Phone: 601-649-9706 Fax: 601-649-9708 |